Samuel Agresta
Nessuna posizione attualmente
Patrimonio netto: 1 $ in data 31/01/2024
Profilo
Samuel Agresta is former Vice President-Clinical Development at Agios Pharmaceuticals, Inc., former Head-Clinical Development at Merrimack Pharmaceuticals, Inc., former Director at Infinity Pharmaceuticals, Inc., former Chief Medical Officer for Foghorn Therapeutics, Inc., former Head-Clinical Development at Genentech, Inc. and former Associate Medical Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc.
Dr. Agresta received an undergraduate degree from Georgetown University, a doctorate from Tulane University School of Medicine, a graduate degree from Tulane University School of Public Health & Tropical Medicine and a graduate degree from the University of South Florida.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
30/05/2023 | 10 593 ( 0.01% ) | 1 $ | 31/01/2024 |
Precedenti posizioni note di Samuel Agresta
Società | Posizione | Fine |
---|---|---|
FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 11/09/2023 |
INFINITY PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 16/10/2019 |
AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2018 |
MERRIMACK PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2011 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/12/2010 |
Formazione di Samuel Agresta
University of South Florida | Graduate Degree |
Georgetown University | Undergraduate Degree |
Tulane University School of Medicine | Doctorate Degree |
Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
INFINITY PHARMACEUTICALS, INC. | Health Technology |
FOGHORN THERAPEUTICS INC. | Health Technology |
Aziende private | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |